NYSE:MMS - MAXIMUS Stock Price, Price Target & More

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

MAXIMUS declared a quarterly dividend on Thursday, July 12th. Shareholders of record on Wednesday, August 15th will be given a dividend of $0.045 per share on Friday, August 31st. This represents a $0.18 annualized dividend and a yield of 0.28%. The ex-dividend date is Tuesday, August 14th. View MAXIMUS's Dividend History.

MAXIMUS declared that its Board of Directors has authorized a share buyback plan on Monday, June 25th 2018, which allows the company to repurchase $200,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to purchase up to 4.9% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's board of directors believes its shares are undervalued.

MAXIMUS, Inc. (NYSE:MMS) issued its quarterly earnings results on Thursday, May, 10th. The health services provider reported $0.82 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.84 by $0.02. The health services provider earned $612.79 million during the quarter, compared to analysts' expectations of $617.97 million. MAXIMUS had a return on equity of 21.67% and a net margin of 9.15%. The firm's revenue for the quarter was down 1.5% on a year-over-year basis. During the same period last year, the company posted $0.80 earnings per share. View MAXIMUS's Earnings History.

MAXIMUS issued an update on its FY18 earnings guidance on Thursday, May, 10th. The company provided EPS guidance of $3.30-3.40 for the period, compared to the Thomson Reuters consensus estimate of $3.49. The company issued revenue guidance of $2.4-2.44 billion, compared to the consensus revenue estimate of $2.50 billion.

3 brokers have issued 12 month price targets for MAXIMUS's stock. Their forecasts range from $64.00 to $81.00. On average, they expect MAXIMUS's stock price to reach $69.50 in the next year. This suggests a possible upside of 7.1% from the stock's current price. View Analyst Ratings for MAXIMUS.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to MAXIMUS include Total System Services (TSS), CoStar Group (CSGP), Worldpay (WP), Msci (MSCI), Mercadolibre (MELI), Broadridge Financial Solutions (BR), Akamai Technologies (AKAM), Zillow Group Inc Class A (ZG), CIELO S A/S (CIOXY), Zillow Group Inc Class C (Z), Alliance Data Systems (ADS), Nielsen (NLSN), GrubHub (GRUB), The Western Union (WU) and CDK Global (CDK).

Media headlines about MMS stock have trended somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. MAXIMUS earned a coverage optimism score of 0.24 on Accern's scale. They also assigned headlines about the health services provider an impact score of 48.05 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

MAXIMUS's stock is owned by many different of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (1.55%), Handelsbanken Fonder AB (0.48%), Summit Creek Advisors LLC (0.25%), West Coast Financial LLC (0.14%), Contravisory Investment Management Inc. (0.11%) and Cambiar Investors LLC (0.11%). Company insiders that own MAXIMUS stock include Anne K Altman, Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Richard John Nadeau and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.

MMS stock was sold by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, Riverbridge Partners LLC, Summit Creek Advisors LLC, Clinton Group Inc., Bank of Montreal Can, West Coast Financial LLC and Contravisory Investment Management Inc.. Company insiders that have sold MAXIMUS company stock in the last year include Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.

MMS stock was bought by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Xact Kapitalforvaltning AB and Cim LLC. Company insiders that have bought MAXIMUS stock in the last two years include Anne K Altman and Richard John Nadeau. View Insider Buying and Selling for MAXIMUS.

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MMS stock can currently be purchased for approximately $64.89.

MAXIMUS has a market capitalization of $4.20 billion and generates $2.45 billion in revenue each year. The health services provider earns $209.42 million in net income (profit) each year or $3.03 on an earnings per share basis. MAXIMUS employs 20,400 workers across the globe.

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]